A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Mellitus

PHASE2CompletedINTERVENTIONAL
Enrollment

318

Participants

Timeline

Start Date

May 24, 2017

Primary Completion Date

August 1, 2018

Study Completion Date

August 1, 2018

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

tirzepatide

Administered SC

DRUG

Dulaglutide

Administered SC

DRUG

Placebo

Administered SC

Trial Locations (49)

10016

Manhattan Medical Research, New York

29461

PMG Research Of Charleston LLC, Moncks Corner

32216

East Coast Institute For Research, Jacksonville

33134

Clinical Research of South Florida, Coral Gables

33135

Suncoast Research Group, LCC, Miami

33175

New Horizon Research Center, Miami

34684

Palm Harbor Medical Associate, Palm Harbor

34761

Sensible Healthcare, Ocoee

36608

Internal Medicine Center LLC, Mobile

37909

New Phase Research & Development, Knoxville

37938

PMG Research Of Knoxville, Knoxville

43213

Aventiv Research, Columbus

50265

Iderc P.L.C., West Des Moines

58103

Lillestol Research LLC, Fargo

63141

Clinical Research Professionals, St Louis

66606

Cotton O'Neil Diabetes and Endocrine, Topeka

75230

Dallas Diabetes Endocrine Center, Dallas

78231

Consano Clinical Research, Shavano Park

83646

Solaris Clinical Research, Meridian

84790

Chrysalis Clinical Research, St. George

89128

Palm Research Center, Las Vegas

90057

National Research Institute, Los Angeles

90101

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Malacky

90255

National Research Institute, Huntington Park

91101

"For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.", Trenčín

For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician., Trenčín

91325

Valley Clinical Trails, Inc, Northridge

91763

Catalina Research Institute, Montclair

91978

Encompass Clinical Research, Spring Valley

92078

Artemis Institute For Clinical Research, San Marcos

92103

Artemis Institute For Clinical Research, San Diego

92780

University Clinical Investigators INC, Tustin

92801

Anaheim Clinical Trails, Anaheim

93720

Valley Research, Fresno

97330

The Corvallis Clinic P.C., Corvallis

06708

Chase Medical Research, Waterbury

01844

ActivMed Practices & Research, Methuen

08611

Premier Research, Trenton

80-546

For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician., Gdansk

81-553

"For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician.", Gdynia

For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician., Gdynia

40-772

For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician., Katowice

90-242

Clinica de Pesquisas e Centro de Estudos em Oncologia Ginecológica e Mamária LTDA, Lodz

70-506

For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician., Szczecin

00674

Manati Center for Clinical Research, Manatí

00909

Clinical Research Puerto Rico. Inc, San Juan

GCM Medical Group PSC, San Juan

04012

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Košice

02001

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Púchov

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT03131687 - A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter